Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Investigating Prognostic Value of Immunoglobulin Next-Generation Sequencing in B Cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy

Yi-Lun Zhang, Lingshuang Sheng, Rong Shen, Wen Wu, Xin Zheng, Li Wang, Shu Cheng, Peng-Peng Xu, Qi-Jie Jian, Bo Peng, Ke Zhang, Fei Pang, Kai Wang, Zi-Xun Yan, Wei-Li Zhao

Blood (2024) 144 (Supplement 1): 6208.

https://doi.org/10.1182/blood-2024-209889

Published: 2024

Journal Articles

Glofitamab Combined with Salvage Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Real-World Prospective Observational Study in Chinese Patients

Jingxian Gu, Tao You, Peng Xu, Jiebing Xiao, Wei Dai, Zhengming Jin, Xiao Ma, Depei Wu, Haiwen Huang

Blood (2024) 144 (Supplement 1): 6530.

https://doi.org/10.1182/blood-2024-203283

Published: 2024

Journal Articles

Cyclophosphamide, Mitoxantrone Hydrochloride Liposome, Vincristine, and Prednisone Regimen with or without Rituximab (CMOP±R) Shows High Efficacy As a First-Line Treatment for Non-Hodgkin's Lymphoma: A Phase II Clinical Trial with Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis

Tao You, Jingxian Gu, Peng Xu, Jiebing Xiao, Huiru Cao, Wei Dai, Jie Bai, Peng Wang, Xiao Ma, Depei Wu, Haiwen Huang

Blood (2024) 144 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2024-204404

Published: 2024

Journal Articles

Ubiquitin-Mediated Degradation of MORF4L1 By FBXO11 Suppresses Cholesterol Biosynthesis in T Cell Acute Lymphoblastic Leukemia

Ye Xin, Xiaowen Chen, Mengli Zhang, Yingcai Jin, Jinchao Xu, Jianxiang Zhang, Xinfeng Chen, Xue Yang, Madeline Niederkorn, Feiqiu Wen, Peng Xu

Blood (2023) 142 (Supplement 1): 4148.

https://doi.org/10.1182/blood-2023-184388

Published: 2023

Journal Articles

Ubiquitin Ligase SCF-FBXO11 Controls a Network of RNA-Binding Proteins and Splicing in MDS

Madeline Niederkorn, Lavanya Bezavada, Anitria Cotton, Lance Palmer, Trent Hall, Michael Schieber, Peng Xu, Mitchell Weiss, Raajit K. Rampal, John D. Crispino

Blood (2023) 142 (Supplement 1): 712.

https://doi.org/10.1182/blood-2023-187094

Published: 2023

Journal Articles

Prime Editing of the α-Thalassemia Hb Constant Spring Mutation

Congwen Shao, Qing Liu, Jinchao Xu, Ye Xin, Jianxiang Zhang, Yuhua Ye, Hualei Luo, Xinhua Zhang, Xiangmin Xu, Peng Xu

Blood (2023) 142 (Supplement 1): 5001.

https://doi.org/10.1182/blood-2023-185425

Published: 2023

Journal Articles

Effectiveness and Safety of a Cmop±R Regimen for the Initial Treatment of Patients with NHL

Yishan Duan, Tao You, Peng Xu, Xiao Ma, Depei Wu, Haiwen Huang

Blood (2023) 142 (Supplement 1): 6244.

https://doi.org/10.1182/blood-2023-187844

Published: 2023

Journal Articles

RNA-Binding Protein RBM5 Plays an Essential Role in Acute Myeloid Leukemia By Activating the Oncogenic Protein HOXA9

Mengli Zhang, Shaela Wright, Xiaowen Chen, Ye Xin, Yingcai Jin, Jianxiang Zhang, Xue Yang, Xinfeng Chen, Judith Hyle, Wojciech Rosikiewicz, Beisi Xu, Liusheng He, Feiqiu Wen, Chunliang Li, Peng Xu

Blood (2023) 142 (Supplement 1): 4130.

https://doi.org/10.1182/blood-2023-182595

Published: 2023

Journal Articles

Regulation of Fetal Hemoglobin Expression By the VHL-HIF1α Oxygen Sensing System

Ruopeng Feng, Thiyagaraj Mayuranathan, Peng Huang, Phillip A Doerfler, Yichao Li, Yu Yao, Jingjing Zhang, Lance E. Palmer, Peng Xu, Kalin Mayberry, Shaela Wright, Chunliang Li, Yong Cheng, Gerd A. Blobel, M. Celeste Simon, Mitchell J. Weiss

Blood (2021) 138 (Supplement 1): 574.

https://doi.org/10.1182/blood-2021-149901

Published: 2021

Journal Articles

Dynamic CTCF binding directly mediates interactions among cis -regulatory elements essential for hematopoiesis

Qian Qi, Li Cheng, Xing Tang, Yanghua He, Yichao Li, Tiffany Yee, Dewan Shrestha, Ruopeng Feng, Peng Xu, Xin Zhou, Shondra Pruett-Miller, Ross C. Hardison, Mitchell J. Weiss, Yong Cheng

Blood (2021) 137 (10): 1327–1339.

https://doi.org/10.1182/blood.2020005780

Published: 2021

Includes: Supplemental data

Journal Articles

FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis

Blood (2021) 137 (2): 155–167.

https://doi.org/10.1182/blood.2020007809

Published: 2021

Includes: Supplemental data

Journal Articles

Shared Expression of CD93 and Other Antigens By AML and Endothelial Cells Highlights a Need for Rational Combinatorial Targeting

Rebecca M Richards, MDPhD, Feifei Zhao, Katherine A Murphy, Peng Xu, MD, Amy Fan, Elena Sotillo, PhD, Mads Daugaard, Htoo Zarni Oo, Jie Liu, Wan-Jen Hong, Poul Sorensen, Robbie G. Majzner, MD, Ravi Majeti, MD PhD, Crystal L. Mackall, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-133988

Published: 2020

Journal Articles

CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-139605

Published: 2020

Journal Articles

Regulation of gene expression by miR-144/451 during mouse erythropoiesis

Peng Xu, Lance E. Palmer, Christophe Lechauve, Guowei Zhao, Yu Yao, Jing Luan, Anastasios Vourekas, Haiyan Tan, Junmin Peng, John D. Schuetz, Zissimos Mourelatos, Gang Wu, Mitchell J. Weiss, Vikram R. Paralkar

Blood (2019) 133 (23): 2518–2528.

https://doi.org/10.1182/blood.2018854604

Published: 2019

Includes: Supplemental data

Journal Articles

Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains

Robbie G. Majzner, MD, Skyler P. Rietberg, Louai Labanieh, Elena Sotillo, PhD, Evan W. Weber, PhD, Rachel C. Lynn, PhD, Johanna L. Theruvath, MD, Constance M. Yuan, MD PhD, Peng Xu, MD, Sang M. Nguyen, BS, Nirali N. Shah, MD, Maryalice Stetler-Stevenson, MD PhD, Terry J. Fry, MD, Daniel W. Lee, MD, Crystal L. Mackall, MD

Blood (2018) 132 (Supplement 1): 963.

https://doi.org/10.1182/blood-2018-99-115558

Published: 2018

Journal Articles

FBXO11 Activates Erythroid Gene Transcription By Degrading Heterochromatin-Associated Protein BAHD1

Peng Xu, PhD, Daniel C. Scott, PhD, Xing Tang, PhD, Yu Yao, MD, Yong-Dong Wang, PhD, Wenjian Bi, PhD, Lance E. Palmer, PhD, Ruopeng Feng, PhD, Arno F. Alpi, PhD, Chunliang Li, PhD, Yong Cheng, PhD, Brenda A. Schulman, PhD, Mitchell J. Weiss, MD PhD

Blood (2018) 132 (Supplement 1): 529.

https://doi.org/10.1182/blood-2018-99-117362

Published: 2018

Journal Articles

MicroRNA21 Sensitized B-Lymphoma Cells to ABT-199 through Modulating ICOS/ICOSL-Mediated Interaction of Regulatory T Cells with Endothelial Cells

Zhong Zheng, Peng-Peng Xu, Li Wang, Hui-Jin Zhao, Wei Li Zhao

Blood (2016) 128 (22): 2942.

https://doi.org/10.1182/blood.V128.22.2942.2942

Published: 2016

Journal Articles

Erythroid miRNA-144/451 Binds Many mRNAs but Regulates Only a Small Subset

Vikram R Paralkar, MD, Lance Palmer, PhD, Peng Xu, PhD, Christophe Lechauve, PhD, Guowei Zhao, PhD, Yu Yao, MD, Gang Wu, PhD, Jing Luan, Mitchell J. Weiss, MD PhD

Blood (2016) 128 (22): 1198.

https://doi.org/10.1182/blood.V128.22.1198.1198

Published: 2016

Journal Articles

Methylation and Silencing of miRNA-124 In Hematopoietic Cells by EVI1

Vitalyi Senyuk, PhD, Kavitha Premanand, Peng Xu, MD, PhD, Francesca Cattaneo, Jerome Dickstein, Giuseppina Nucifora

Blood (2010) 116 (21): 2476.

https://doi.org/10.1182/blood.V116.21.2476.2476

Published: 2010

NARROW

Investigating Prognostic Value of Immunoglobulin Next-Generation Sequencing in B Cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy

Glofitamab Combined with Salvage Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Real-World Prospective Observational Study in Chinese Patients

Cyclophosphamide, Mitoxantrone Hydrochloride Liposome, Vincristine, and Prednisone Regimen with or without Rituximab (CMOP±R) Shows High Efficacy As a First-Line Treatment for Non-Hodgkin's Lymphoma: A Phase II Clinical Trial with Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis

Ubiquitin-Mediated Degradation of MORF4L1 By FBXO11 Suppresses Cholesterol Biosynthesis in T Cell Acute Lymphoblastic Leukemia

Ubiquitin Ligase SCF-FBXO11 Controls a Network of RNA-Binding Proteins and Splicing in MDS

Prime Editing of the α-Thalassemia Hb Constant Spring Mutation

Effectiveness and Safety of a Cmop±R Regimen for the Initial Treatment of Patients with NHL

RNA-Binding Protein RBM5 Plays an Essential Role in Acute Myeloid Leukemia By Activating the Oncogenic Protein HOXA9

Regulation of Fetal Hemoglobin Expression By the VHL-HIF1α Oxygen Sensing System

Dynamic CTCF binding directly mediates interactions among cis -regulatory elements essential for hematopoiesis

FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis

Shared Expression of CD93 and Other Antigens By AML and Endothelial Cells Highlights a Need for Rational Combinatorial Targeting

CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering

Regulation of gene expression by miR-144/451 during mouse erythropoiesis

Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains

FBXO11 Activates Erythroid Gene Transcription By Degrading Heterochromatin-Associated Protein BAHD1

MicroRNA21 Sensitized B-Lymphoma Cells to ABT-199 through Modulating ICOS/ICOSL-Mediated Interaction of Regulatory T Cells with Endothelial Cells

Erythroid miRNA-144/451 Binds Many mRNAs but Regulates Only a Small Subset

Methylation and Silencing of miRNA-124 In Hematopoietic Cells by EVI1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only